K Li, H Wu, W Pan, M Guo, D Qiu, Y He, Y Li,
DH Yang… - Molecular cancer, 2022 - Springer
Background Patients with relapsed/refractory acute myeloid leukaemia (AML) with FMS-like
tyrosine kinase 3-internal tandem duplication (FLT3-ITD) have limited treatment options and …